Modulator therapy does not appear to affect the magnitude of lung function impairment or recovery pattern during pulmonary ...
Regardless of blood eosinophil count threshold, adults with COPD and an eosinophilic phenotype experienced significantly fewer moderate/severe exacerbations in a year with mepolizumab vs. placebo, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback